Advertisement
Advertisement

VIGL

VIGL logo

Vigil Neuroscience Inc

1.61
USD
-0.02
-1.23%
Dec 26, 09:32 UTC -5
Open

Vigil Neuroscience Inc Profile

About

Vigil Neuroscience Inc. is a microglia-focused therapeutics company. It focused on developing treatments for both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. Vigil Neuroscience Inc. is based in CAMBRIDGE, Mass.

Info & Links

CEO

Ivana Magovcevic-Liebisch

Headquarters

100 FORGE ROAD, SUITE 700
WATERTOWN, MA 02472, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

12

Employees

90

Vigil Neuroscience Inc Statistics

Valuation Measures

Market Capitalization2

65.82M

Enterprise Value

20.92M

Enterprise Value/EBITDA(ttm)

-0.24

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.76

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-83.89%

Return on Invested Capital(ttm)

-84.93%

Return on Assets(ttm)

-65.34%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-88.91M

Net Income Available to Common(ttm)

-82.60M

Diluted EPS(ttm)

-2.06

Share Statistics

Beta (5Y Monthly)

1.66

52-Week Change

-51.65%

S&P 500 52-Week Change

26.50%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

40.88M

Dividend Yield

0.00%

Float4

27.38M

% Held by Insiders

33.03%

% Held by Institutions

83.64%

Balance Sheet

Total Cash(mrq)

111.27M

Total Cash Per Share(mrq)

2.72

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.72%

Quick Ratio(mrq)

3.72%

Book Value Per Share(mrq)

2.23

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.82

Free Cash Flow(ytd)

-33.09M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement